Berry Genomics Co.,Ltd (SHE:000710)
China flag China · Delayed Price · Currency is CNY
9.35
-0.03 (-0.32%)
Sep 22, 2026, 9:35 AM CST

Berry Genomics Co.,Ltd Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-213.54-196.84-192.43-427.2-248.93-110.82
Depreciation & Amortization
85.6587.9492113.94102.72106.4
Other Amortization
17.1414.698.368.9112.5613.83
Loss (Gain) From Sale of Assets
-3.13-5-1.740.010.35-0.26
Asset Writedown & Restructuring Costs
0.580.250.66159.380.075.16
Loss (Gain) From Sale of Investments
126.3840.1682.67144.3149.13
Provision & Write-off of Bad Debts
109.29102.52130.68162.779853.6
Other Operating Activities
9.215.7419.3521.475.5431.98
Change in Accounts Receivable
-40.3763.2-16.6983.22-24.6-134.88
Change in Inventory
17.2118.8331.950.896.85-57.53
Change in Accounts Payable
11.71-29.68-30.3-38.2-88.03152.02
Change in Other Net Operating Assets
-2.1-2.10.63-11.2650.7422.42
Operating Cash Flow
0.2570.6187.97111.0121.1894.03
Operating Cash Flow Growth
-99.41%-19.74%-20.75%424.14%-77.48%-41.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-64.33-75.68-56.75-55.1-73.31-336.69
Sale of Property, Plant & Equipment
15.9712.07421.040.130.090.43
Divestitures
----1.71-
Investment in Securities
-15.76-2.13-171.50.620.22-11.21
Other Investing Activities
---2.3671.87-
Investing Cash Flow
-64.13-65.74190.43-47.37-49.42-347.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-182.85123.3---
Long-Term Debt Issued
---212.43286.27207.87
Total Debt Issued
149.64182.85123.3212.43286.27207.87
Short-Term Debt Repaid
--141.98-296.79---
Long-Term Debt Repaid
--14.98-56.74-264.22-339.28-199.05
Lease Payments
-19.5-14.98-56.74-8.52--
Total Debt Repaid
-213.15-156.96-353.54-264.22-339.28-199.05
Net Debt Issued (Repaid)
-63.5125.89-230.24-51.79-53.018.82
Issuance of Common Stock
-----56.46
Repurchase of Common Stock
-9.46-9.46----
Common Dividends Paid
-5.09-4.73-8.69-15.5-28.29-9.59
Other Financing Activities
30.360.361.09---10.85
Financing Cash Flow
-47.712.06-237.85-67.29-81.344.84

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-4.27-3.031.631.511.19-2.67
Net Cash Flow
-115.8513.8942.18-2.15-98.35-211.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-64.08-5.0831.2255.91-52.13-242.66
Free Cash Flow Growth
---44.16%---
Free Cash Flow Margin
-6.90%-0.55%2.90%4.86%-3.81%-17.06%
Free Cash Flow Per Share
-0.18-0.010.090.16-0.17-0.68
Levered Free Cash Flow
46.6383.3316.38206.9718.73-210.42
Unlevered Free Cash Flow
53.1689.5722.52217.1929.75-197.73
Free Cash Flow After Leases
-83.58-20.06-25.5347.39-52.13-242.66

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
54.8346.4963.5846.39-3.2771.81
Change in Working Capital
-16.9544.93-9.07-10.95-93.45-54.99